Illinois Tool Works Inc (ITW)

ITW (NYSE:Industrial) EQUITY
$130.42
pos +0.30
+0.23%
Today's Range: 129.37 - 130.86 | ITW Avg Daily Volume: 1,289,000
Last Update: 02/23/17 - 4:02 PM EST
Volume: 1,588,962
YTD Performance: 6.49%
Open: $130.48
Previous Close: $130.12
52 Week Range: $92.99 - $130.90
Oustanding Shares: 346,550,685
Market Cap: 45,193,674,831
6-Month Chart
TheStreet Ratings Grade for ITW
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 7 7
Moderate Buy 0 0 0 0
Hold 6 7 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.92 2.00 2.00 2.00
Latest Dividend: 0.65
Latest Dividend Yield: 1.99%
Dividend Ex-Date: 03/29/17
Price Earnings Ratio: 22.88
Price Earnings Comparisons:
ITW Sector Avg. S&P 500
22.88 22.90 30.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
5.61% 35.74% 60.05%
GROWTH 12 Mo 3 Yr CAGR
Revenue 1.40 0.00 -0.01
Net Income 7.20 0.20 0.08
EPS 11.10 0.50 0.15
Earnings for ITW:
EBITDA 3.53B
Revenue 13.60B
Average Earnings Estimates
Qtr (03/17) Qtr (06/17) FY (12/17) FY (12/18)
Average Estimate $1.44 $1.59 $6.18 $6.90
Number of Analysts 9 9 10 9
High Estimate $1.46 $1.62 $6.22 $7.30
Low Estimate $1.41 $1.55 $6.11 $6.70
Prior Year $1.29 $1.46 $5.64 $6.18
Growth Rate (Year over Year) 11.71% 8.83% 9.52% 11.72%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Bearish
Feb 17, 2017 | 7:44 AM EST
ITW was downgraded from Neutral to Sell, Goldman Sachs said. $121 price target. Company has low cyclical exposure and earnings upside p...
The market has fewer defenders.
Today high-growth tech and natural resources stocks are both going higher without sending much lower at all.
But if you do, accept that you aren't necessarily selling expensive stocks.
Bearish
Nov 21, 2016 | 6:31 AM EST
ITW was downgraded to Neutral, Goldman Sachs said. $125 price target. Valuation call, as the stock is trading at 20x expected 2017 earn...
Bids abound for companies that were recently getting whacked.
We saw this weakness coming.
Traders with a high cost basis might consider selling or reducing their exposure on any weakness.
I learned a long time ago, don’t outthink it.
But perhaps the economy is a bit like the Washington gridlock.

Columnist Conversations

The SPDR S&P Biotech ETF (XBI) was trading in a four month symmetrical triangle before it broke out o...
Join me later today as I bring back Toni Hanser to a webinar.  Toni has been away for awhile recovering f...
Here is a well defined zone to look for buy triggers against...defining the risk below it! View Char...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.